Louise E. Harris
Growth hormone secretagogue receptor deficiency in mice protects against obesity-induced hypertension
Harris, Louise E.; Morgan, David G.; Balthasar, Nina
Abstract
Growth hormone secretagogue receptor (GHS-R) signaling has been associated with growth hormone release, increases in food intake and pleiotropic cardiovascular effects. Recent data demonstrated that acute GHS-R antagonism leads to increases in mean arterial pressure mediated by the sympathetic nervous system in rats; a highly undesirable effect if GHS-R antagonism was to be used as a therapeutic approach to reducing food intake in an already obese, hypertensive patient population. However, our data in conscious, freely moving GHS-R deficient mice demonstrate that chronic absence of GHS-R signaling is protective against obesity-induced hypertension. GHS-R deficiency leads to reduced systolic blood pressure variability (SBPV); in response to acute high-fat diet (HFD)-feeding, increases in the sympathetic control of SBPV are suppressed in GHS-R KO mice. Our data further suggest that GHS-R signaling dampens the immediate HFD-mediated increase in spontaneous baroreflex sensitivity. In diet-induced obesity, absence of GHS-R signaling leads to reductions in obesity-mediated hypertension and tachycardia. Collectively, our findings thus suggest that chronic blockade of GHS-R signaling may not result in adverse cardiovascular effects in obesity.
Citation
Harris, L. E., Morgan, D. G., & Balthasar, N. (2014). Growth hormone secretagogue receptor deficiency in mice protects against obesity-induced hypertension. Physiological Reports, 2(3), e00240-?. https://doi.org/10.1002/phy2.240
Journal Article Type | Article |
---|---|
Acceptance Date | Jan 26, 2014 |
Online Publication Date | Mar 3, 2014 |
Publication Date | 2014-03 |
Publicly Available Date | May 26, 2023 |
Journal | Physiological Reports |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 2 |
Issue | 3 |
Pages | e00240-? |
DOI | https://doi.org/10.1002/phy2.240 |
Keywords | diet-induced obesity, ghrelin, growth hormone secretagogue receptor, hypertension |
Publisher URL | https://doi.org/10.1002/phy2.240 |
Files
e00240.full.pdf
(419 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Pharmacological properties of rutin and its potential uses for Alzheimer’s disease.
(2020)
Journal Article
Proteomic analysis of age-related changes in ovine cerebrospinal fluid
(2018)
Journal Article
Discovery of a series of 2-(pyridinyl) pyrimidines as potent antagonists of GPR40
(2015)
Journal Article
Identification, optimization, and pharmacology of acylurea GHS-R1a inverse agonists
(2014)
Journal Article
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search